Firm files health claim for probiotic and Herpes labialis recurrence

By Annie Harrison-Dunn

- Last updated on GMT

'Consumption of Lactobacillus rhamnosus and fructooligosaccharides helps to reduce Herpes labialis recurrence,' claims Granarolo Spa
'Consumption of Lactobacillus rhamnosus and fructooligosaccharides helps to reduce Herpes labialis recurrence,' claims Granarolo Spa
Italian dairy firm Granarolo Spa has applied for a health claim for a probiotic – prebiotic combination and the reduced recurrence of cold sores.

The article 13.5 claim read: “Consumption of Lactobacillus rhamnosus GG (ATCC 53103) and fructooligosaccharides (FOS) helps to reduce Herpes labialis recurrence.”

Herpes labialis, also known as cold sores, is a type of herpes causing small blisters or sores on or around the mouth.

It is subject to some social stigmatism due to its relation to the sexually transmitted type 2 herpes simplex virus (HSV-2), which more commonly causes genital infections. While cold sores can also be caused by HSV-2, this is rare.

Most cold sores disappear within seven to ten days without treatment, yet some people experience recurrent cold sores in the same place.

A 2009 US study​ found the global prevalence of HSV1 increased consistently with age, reaching 40% by age 15 and 60% to 90% in older adults.

A history of probiotic claims

There have been 41 EU health claim applications concerning the probiotic strain Lactobacillus rhamnosus ​– all of which have been unsuccessful.

Much of the attempted probiotic claims related to gut health.

This was the first health claim application across all ingredients for prevention of cold sores.

According to EFSA’s register of questions the claim was now under consideration although an exact deadline was not given.

Granarolo did not respond to our request for comment in time for the publication of this article.

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Looking to capitalize on market trends quickly?

Looking to capitalize on market trends quickly?

Content provided by Lonza | 25-Sep-2024 | Product Brochure

Lonza’s ready-to-go formulas can help you keep up with the most in-demand health categories, including joint health & mobility, digestive health (probiotics),...

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

Related suppliers

Follow us

Products

View more

Webinars